{"version":"1.0","type":"link","title":"Programmed cell death 1 inhibitor sintilimab plus S-1 and gemcitabine for liver metastatic pancreatic ductal adenocarcinoma.","author_name":"Zhou SQ 외","author_url":"https://prs-insight.online/author/Zhou%20SQ","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/154283","thumbnail_width":1200,"thumbnail_height":630}